Back to results
US 2026/0014281 A1Published application
Peg targeting compounds for delivery of therapeutics
AssigneeModernaTX, Inc.
InventorsMohindra SEEPERSAUD, Junyong KIM, Ellalahewage Sathyajith KUMARASINGHE, Sreyoshi SUR
Life of this patent
Estimating the term…
Abstract
Provided herein are targeting compounds (e.g., a compound of Formula I, a stereoisomer thereof, a tautomer thereof, and/or a pharmaceutically acceptable salt thereof), lipid nanoparticle (LNP) compositions comprising such targeting compounds and the use thereof. The LNP compositions described herein may further comprise one or more selected from ionizable lipids, PEG-lipids, phospholipids, and structural lipids.
Claims20
A targeting compound of Formula I, a stereoisomer thereof, a tautomer thereof, and/or a pharmaceutically acceptable salt thereof:
- wherein,
- R1, R2, R3, R4, R5, and R6 at each occurrence are independently H or a C1-6 alkyl group;
- R7 is H or a C1-6 alkyl group;
- Y1 is absent, or an O, C1-6 alkylene-O, NH, C1-6 alkylene-NH, or C1-6 alkylene group;
- Y2 is absent, or an O, C1-6 alkylene-O, NH, C1-6 alkylene-NH, C(O)O, C(O)O—C1-6 alkylene, C(O)NH, or C(O)NH—C1-6 alkylene group;
- X1, X2 and X3 are, at each occurrence, independently absent, C(O), C(O)O, or C(O)NH;
- L1, L2, and L3 are, at each occurrence, independently selected from an alkylene, alkenylene, heteroalkylene, cycloalkylene, heterocyclylene, arylene, or heteroarylene group, or any combination of 2 or 3 of the foregoing groups;
- G1, G2, and G3 are each independently selected from an asialoglycoprotein receptor targeting monosaccharide;
- PEG is a poly(ethylene glycol) having 1 to 100 ethylene oxy subunits;
- DA is di(C12-24 alkanoyl)glycero or di(C12-24 alkyl)glycero;
- m is 2, 3, 4, 5 or 6;
- n, and p are each independently selected from 1, 2, 3, 4, 5, or 6;
- q is 0, 1, 2, 3, 4, 5, or 6;
- and
- r, s, and t are each independently 1, 2, 3, or 4.
12 more elements
Dependencies are inferred from the claim text.